Gynecology medicine franchise in Ahmedabad

Mifepristone Misoprostol tablet supplier in Mumbai

Women's healthcare medicine distributor in Delhi

Gynecology tablet manufacturer in Bangalore

Reproductive health medicine stockist in Hyderabad
Pharmaceutical exporter in Chandigarh

Home/Products /mifepristone-200mg-misoprostol-200mcg-tablet

About the Product

Description


Fibromiss M Tablet contains Mifepristone 200 mg and Misoprostol 200 mcg, a combination medicine used for medical termination of intrauterine pregnancy under the supervision of a qualified healthcare professional. The combination is widely utilized in gynecological practice and plays an important role in reproductive healthcare when prescribed according to approved medical guidelines. Its effectiveness and established clinical use have made it a significant product within the women's healthcare segment.

Mifepristone works by blocking the action of progesterone, a hormone necessary for the continuation of pregnancy. Misoprostol subsequently induces uterine contractions and cervical changes that facilitate the expulsion of pregnancy tissue. Together, these medicines provide a well-established pharmacological approach for medical pregnancy termination when used under appropriate medical supervision and according to prescribed treatment protocols.

The tablet combination is prescribed only under the guidance of a registered healthcare professional and requires proper clinical evaluation before use. Appropriate patient selection, counseling, and follow-up are important components of treatment to ensure safety and effectiveness. The medicine should be used strictly according to approved prescribing information and applicable regulatory requirements.

With increasing awareness of reproductive healthcare and the continued demand for evidence-based gynecological treatment options, Fibromiss M Tablet maintains relevance in the women's healthcare segment. Its established therapeutic role, physician acceptance, and importance in reproductive health management contribute to consistent market potential. The product offers valuable business opportunities for retailers and distributors operating within the gynecology pharmaceutical sector.

Fibromiss M Tablet may cause abdominal pain, uterine cramping, vaginal bleeding, nausea, vomiting, diarrhea, headache, dizziness, fatigue, fever, or chills. Excessive bleeding, severe pain, infection, or other serious complications require immediate medical attention.

Fibromiss M Tablet is indicated for medical termination of intrauterine pregnancy as advised and supervised by a qualified healthcare professional in accordance with approved medical guidelines and applicable regulations.

Regulated Prescription Medicine: Mifepristone and Misoprostol are prescription medicines that should only be used under the direct supervision of a qualified healthcare professional. The product must not be self-administered without proper medical evaluation, diagnosis, and follow-up. Patients should seek immediate medical attention if they experience excessive bleeding, severe abdominal pain, high fever, fainting, or other unusual symptoms. Use must comply with all applicable local laws, regulations, and prescribing requirements.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children. Do not use after the expiry date or if the packaging is damaged, opened, or shows signs of tampering.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions